Viewing Study NCT03175692


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-01-29 @ 2:36 AM
Study NCT ID: NCT03175692
Status: UNKNOWN
Last Update Posted: 2017-06-16
First Post: 2017-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
Sponsor: National Taiwan University Hospital
Organization:

Study Overview

Official Title: Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
Status: UNKNOWN
Status Verified Date: 2017-05
Last Known Status: ENROLLING_BY_INVITATION
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Under the joint efforts of genetic and intensive expert, to establish the high-throughput whole exon sequencing(WES) and analysis all the possible pathogenic genes. To provide patient with the appropriate treatment for genetic disease. Besides, it can identify the genetic factor of idiosyncrasy or susceptibility to explain the medical difficulties and give patients personalized advice.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: